|
LE Magazine September 1997

Guiding Us in Our Quest
Tapping into expensive expertise of these
researchers and physicians is crucial step in helping the
Foundation find ways to enhance and extend life.
Two years ago, the Life Extension Foundation launched an
unprecedented research program called Project 2020 to achieve
control over aging and death by the year 2020. Since then,
the Foundation has begun to fund three Project 2020 research
programs: the Lifespan Project for therapies to slow the aging
process; the Rejuvenation Project for therapies to reverse
the aging process; and the Suspended Animation Project to
stop death cold in its tracks.
Thus far, the Foundation has committed more than $2 million
towards these research programs. In the years to come, we
plan to invest a great deal more money in these and other
research programs. In the months to come, you will be reading
about our funding of several more path-breaking anti-aging
research studies.
To help guide us in our quest to achieve healthier, happier,
longer life spans, we've brought together some of the leading
authorities in life extension science and medicine to form
our Scientific Advisory Board. We expect to tap the expertise
of these eminent scientists and physicians for the design
and analysis of the studies we fund. Several members of the
board are already working with us to carry out Project 2020
research. We will be adding more members to the board, as
our need for expertise expands into other areas of science
and medicine.
Roy Walford, M.D., is a longtime professor
of pathology at the University of California, Los Angeles, the
writer of more than 300 scientific articles, and mentor to many
fellow scientists in life extension research. Dr. Walford has
conducted research aimed at slowing aging and extending life
span via calorie restriction, body temperature reduction, and
the investigation of the role of histocompatibility (MHC) genes
in aging. He is the originator of the immunologic theory of
aging, and his book on the subject, published in 1969, is a
classic work in gerontology.
Among the numerous awards presented to Dr. Walford are the
American Aging Association Research Award, the Kleemeler Award
from the Gerontological Society, and the Infinity Award from
the American Academy of Anti-Aging Medicine. He has served
on numerous editorial boards of scientific journals.
Among Dr. Walford's unique contributions to the nation's
health and culture, he served as chief of medical operations
for Biosphere 2; has written book and poetry reviews and travel
articles for a number of publications; and is a published
poet and actor as well as an artist. Among his books for the
general public is Maximum Life Span.
Denham Harman, M.D., Ph.D., is the originator
of the free radical theory of aging. His early ideas about
the role of free radicals in aging and degenerative disease,
and his pioneering research studies with antioxidants paved
the way for the explosion of biological and medical interest
in this field in recent years.
For decades, Dr. Harman has worked as a researcher and practicing
physician at the University of Nebraska Medical Center in
Omaha. He is founder and director of the American Aging Association
(AGE) and the International Association of Biomedical Gerontology.
The conferences sponsored by these organizations provide ideal
forums for cutting-edge biomedical anti-aging research.
Richard Weindruch, Ph.D., is Professor in
the Department of Medicine at the University of Wisconsin-Madison.
He is director of the Wisconsin Regional Primate Research
Center's Aging Research Group, which is conducting a
long-term calorie restriction research study in monkeys. He
also is director of the Cellular and Molecular Biology Laboratory,
as well as the Shared Aging Rodent Facility, at the Geriatric
Research, Education and Clinical Center at the Veterans Administration
Hospital in Madison. His 20-year research career has focused
on the retardation of aging by caloric restriction.
Dr. Weindruch holds a Ph.D. in Experimental Pathology from
UCLA, and his doctoral work was conducted under fellow board
member Roy Walford, with whom he collaborated on numerous
studies. Besides co-directing the Lifespan Project (with Dr.
Spindler), he also is chairman of the National Institutes
of Health's Geriatrics and Rehabilitative Medicine Study Section.
Stephen R. Spindler, Ph.D., is Professor
of Biochemistry at the University of California-Riverside.
He has served as a member of the Physiological Sciences Study
Section of the National Institutes of Health. For the past
12 years, Dr.
Spindler has been investigating the molecular-genetic mechanisms
of aging retardation and life span extension by calorie restriction.
Dr. Spindler earned his undergraduate degree in biology at
the University of California-San Diego, and his Ph.D. in Biomedical
Sciences with a major in Biochemistry from the University
of Texas Graduate School of Biomedical Sciences in Houston.
He has published more than 50 scientific papers.
Dr. Spindler and Dr. Richard Weindruch are directing the
Life Extension Foundation's ground breaking Lifespan Project,
the first large-scale, coordinated program to investigate
the effects of dietary agents on aging and life span. The
project began last month at Dr. Spindler's facilities and
at the University of Wisconsin.
Steven B. Harris, M.D., is Medical Director
and a research scientist at 21st Century Medicine in Rancho
Cucamonga, Calif., where he participates in ground breaking
hypothermia, cryothermia and ischemia research. He also is
staff geriatrician at the IHC Senior Clinic in Salt Lake City,
Utah, and contributes to the Foundation's Lifespan Project.
Prior to working at 21st Century Medicine, Dr. Harris was
a researcher at the laboratory of fellow board member Roy
Walford, M.D., at UCLA Medical Center, where he supervised
the rodent nutrition/aging program. His major anti-aging research
interests include antioxidant and dietary restriction effects
in animals and humans.
L. Cass Terry, M.D., Ph.D., is chairman of
the Department of Neurology at the Medical College of Wisconsin,
and chief of staff at Froedtert Memorial Lutheran Hospital,
Milwaukee. He has received numerous grants and awards for
his research, and is an editorial consultant with several
scientific and medical journals. One of Dr. Terry's major
research interests is the effects of human growth hormone
therapy on human aging. Dr. Terry received his medical degree
from Marquette University Medical School, and his Ph.D. from
McGill University Medical School.
Don Ingram, Ph.D., is a research psychologist at the Nathan
W. Schock Laboratories, Gerontology Research Center, National
Institute on Aging, at the Johns Hopkins Bayview Medical Center
in Baltimore, Md. Dr. Ingram has conducted research on therapeutic
agents designed to improve mental function in aging and dementia.
He is a participating scientist in one of two long-term studies
to determine the effects on aging and life span of caloric
restriction in monkeys.
With a Ph.D. from the University of Georgia, Dr. Ingram is
currently president of the American Aging Association (AGE),
is a fellow of the Gerontological Society of America, and
has served on the editorial and advisory boards of several
medical journals. In 1996, Dr. Ingram received the Merit Award
from the National Institutes of Health.
Don Kleinsek, Ph.D., is president and founder of GeriGene
Medical Corp., in Madison, Wisc. GeriGene's mission is to
stop the aging process. Dr. Kleinsek is using state-of-the-art
genetic research techniques to find, investigate and modify
genes involved in the aging process.
Dr. Kleinsek received a Ph.D. from the University of Wisconsin
at Madison in Physiological Chemistry. In addition to his
entrepreneurial efforts with GeriGene, he is an associate
scientist with the Institute on Aging. He owns five patents
with more pending, and there are 35 patents by others based
on Dr. Kleinsek's research on cholesterol metabolism.
Karlus Ullis, M.D., is one of the world's foremost sports
medicine physicians. Since 1978, Dr. Ullis has focused on
sports medicine care for UCLA intercollegiate athletes, recreational
athletes, and world-class athletes. He has treated many Olympic
Games gold medal winners and world record holders, and has
been a team physician in five Olympic Games. Dr. Ullis' specialty
is the diagnosis and rehabilitation of musculo-skeletal injuries
(acute and chronic) and pain control. He has been involved
in helping athletes achieve optimum performance levels, including
metabolic, hormonal and nutritional interventions, with pertinent
applications in the anti-aging arena. Dr. Ullis is in private
practice in Santa Monica, Calif.
Arnold Fox, M.D., is an internist, cardiologist and practicing
physician in Beverly Hills, Calif. With more than 40 years
experience in the front lines of medicine, Dr. Fox specializes
in anti-aging medicine. His practice utilizes nutritional
and hormone replacement therapies for the prevention and treatment
of premature aging and the diseases of aging, as well as more
traditional medicine.
Currently an adjunct professor at the University of the Pacific,
Dr. Fox was a professor at the University of California-Irvine
College of Medicine, is a commissioner for the Medical Board
of California, and is on the board of directors of the American
Academy of Pain Management. Dr. Fox is the author of a number
of books for the general public. His latest is The Fat Blocker
Diet.
Back to the
Magazine Forum
|